Impact of COVID-19 pandemic on epilepsy practice in India: A tripartite survey.
Adolescent
Adult
Aged
Anticonvulsants
/ administration & dosage
COVID-19
/ epidemiology
Child
Child, Preschool
Electroencephalography
/ statistics & numerical data
Epilepsy
/ epidemiology
Female
Health Care Surveys
Health Services Accessibility
/ statistics & numerical data
Hospitals, Special
/ statistics & numerical data
Humans
India
/ epidemiology
Infant
Male
Middle Aged
Neurologists
/ statistics & numerical data
Outpatients
/ statistics & numerical data
Remote Consultation
/ statistics & numerical data
Young Adult
COVID-19 pandemic
Epilepsy
Lockdown
Teleconsultation
Journal
Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
19
11
2020
revised:
15
12
2020
accepted:
31
12
2020
pubmed:
8
2
2021
medline:
31
3
2021
entrez:
7
2
2021
Statut:
ppublish
Résumé
To assess the impact of ongoing COVID-19 pandemic on epilepsy care in India. We conducted a three-part survey comprising neurologists, people with epilepsy (PWE), and 11 specialized epilepsy centers across India. We sent two separate online survey questionnaires to Indian neurologists and PWE to assess the epilepsy practice, seizures control, and access to care during the COVID-19 pandemic. We collected and compared the data concerning the number of PWE cared for and epilepsy procedures performed during the 6 months periods preceding and following COVID-19 lockdown from epilepsy centers. The survey was completed by 453 neurologists and 325 PWE. One third of the neurologist reported >50 % decline in outdoor visits by PWE and EEG recordings. The cumulative data from 11 centers showed 65-70 % decline in the number of outdoor patients, video-EEG monitoring, and epilepsy surgery. Working in a hospital admitting COVID-19 patients and use of teleconsultation correlated with this decline. Half of PWE had postponed their planned outpatient visits and EEG. Less than 10 % of PWE missed their antiseizure medicines (ASM) or had seizures due to the nonavailability of ASM. Seizure control remained unchanged or improved in 92 % PWE. Half of the neurologists started using teleconsultation during the pandemic. Only 4% of PWE were afflicted with COVID-19 infection. Despite significant decline in the number of PWE visiting hospitals, their seizure control and access to ASMs were not affected during the COVID-19 pandemic in India. Risk of COVID-19 infection in PWE is similar to general population.
Identifiants
pubmed: 33550135
pii: S1059-1311(21)00001-7
doi: 10.1016/j.seizure.2020.12.025
pmc: PMC7837209
pii:
doi:
Substances chimiques
Anticonvulsants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
60-67Informations de copyright
Copyright © 2021 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Références
Acta Neurol Scand. 2020 Dec;142(6):545-554
pubmed: 32799337
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):273-276
pubmed: 32283497
Lancet. 2020 Apr 25;395(10233):1315
pubmed: 32334687
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104988
pubmed: 32689650
J Educ Health Promot. 2020 Jul 28;9:190
pubmed: 32953916
Eur Neurol. 2020;83(2):213-215
pubmed: 32289789
Epilepsy Curr. 2020 Sep;20(5):316-324
pubmed: 32942901
Can J Cardiol. 2020 Jul;36(7):1068-1080
pubmed: 32425328
Neurology. 2020 Jun 9;94(23):1032-1037
pubmed: 32327490
Neurol India. 2017;65(Supplement):S52-S59
pubmed: 28281496
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Lancet Oncol. 2020 Jul;21(7):884
pubmed: 32479789
Neurology. 2020 Jan 7;94(1):30-38
pubmed: 31801829
Neurology. 2020 Sep 1;95(9):e1257-e1266
pubmed: 32518152
Ann Indian Acad Neurol. 2021 Jan-Feb;24(1):51-55
pubmed: 33911379
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114